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ABSTRAK 
 
Hipertensi adalah salah satu punca utama yang menyumbang kepada penyakit 
kardiovaskular. Salah satu tumbuhan perubatan tempatan yang dilaporkan mempunyai 
potensi sebagai anti-hipertensi adalah Syzygium polyanthum (serai kayu). Oleh itu, 
kajian ini dijalankan untuk mengkaji ekstrak akuas S. polyanthum (AESP) sebagai ejen 
antihipertensi yang berpotensi dalam model tikus hipertensi spontan (SHR). Kajian ini 
menggunakan 35 ekor tikus jantan SHR yang telah dibahagikan kepada 5 kumpulan; 
SHR yang tidak dirawat, rawatan dengan Losartan, rawatan dengan 3 dos AESP yang 
berbeza (1500mg/kg, 1750mg/kg dan 2250mg/kg) bersama dengan 7 ekor tikus jantan 
WKY sebagai kawalan normal dirawat secara oral selama 92 hari. Hasil rawatan 
dengan AESP dinilai dengan mengukur pengurangan tekanan darah sistolik (SBP) 
menggunakan teknik tidak invasif (tail-cuff). Sementara itu, perubahan morfologi 
torasik aorta dan ginjal tikus dinilai melalui pemerhatian pada pewarnaan hematoksilin 
& eosin serta mikroskop imbasan electron (SEM). Ujian Fungsi Renal (RFT), aktiviti 
antioksidan (FRAP) dan jumlah kandungan fenolik terkumpul (TPC) di dalam AESP 
juga telah dinilai dalam kajian ini. Hasil kajian mendapati, AESP menurunkan bacaan 
SBP tikus SHR dengan ketara, dan hampir setanding dengan kumpulan kawalan 
normal pada minggu ke-8 untuk kumpulan yang dirawat, manakala pada minggu ke-
10 setanding dengan kumpulan rawatan dengan Losartan. Pada penghujung minggu 
ke-12, bacaan SBP untuk kumpulan yang dirawat dengan AESP bersamaan dengan 
kumpulan WKY dan lebih rendah dari kumpulan yang dirawat dengan Losartan. Dos 
terendah (1500mg/kg) telah dipilih sebagai dos efektif. Tambahan pula, AESP juga 
telah berjaya menambahbaik struktur morfologi torasik aorta dan ginjal tikus. 
Penambahbaikan struktur morfologi organ yang dikaji boleh dikaitkan dengan 
kandungan fenolik dan kadar antioksidan yang tingi dijumpai di dalam AESP. Tiada 
perbezaan yang ketara dalam RFT antara kumpulan kajian. Adalah dicadangkan 
bahawa biarpun terdapat perubahan morfologi ginjal yang ketara disebabkan oleh 
kesan hipertensi selama 3 bulan, namun tiada kesan kepada fungsinya. Jadi, kajian ini 
mencadangkan bahawa S. polyanthum mempunyai potensi sebagai ejen antihipertensi 
dan boleh mengurangkan kesan kerosakan organ akhir dalam penyakit hipertensi. 
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ABSTRACT 
 
Hypertension remains a major modifiable risk factor for cardiovascular disease 
(CVD). One of the local medicinal plant reported could be potentially served as 
antihypertensive agent is Syzygium polyanthum (serai kayu). Therefore, this study 
aims to evaluate the aqueous extract of S. polyanthum (AESP) as potential 
antihypertensive agent in spontaneous hypertensive rat model (SHR). This study 
employed 35 male SHR which then was further divided into 5 group; untreated-SHR, 
Losartan-treated, 3 AESP-treated with different dosages (1500 mg/kg,1750 mg/kg and 
2250 mg/kg) along with 7 male WKY rats as normal control orally treated for 92 days. 
The effects of AESP were evaluated by measuring the reduction of systolic blood 
pressure (SBP) using non-invasive tail-cuff method. Meanwhile, morphology changes 
of the thoracic aorta and kidney was assessed using haematoxylin & eosin staining 
observation as well as Scanning Electron Microscope (SEM). Renal function test 
(RFT), antioxidant activity (FRAP) and total phenolic content (TPC) of AESP were 
also evaluated in this study. The results of the study suggested that, all three doses of 
AESP significantly reduced SBP of SHR rat comparable to normal WKY rat at 8th 
week, while at 10th week comparable to Losartan-treated group. At the end of 12th 
week, SBP of the AESP-treated group are similar to WKY group and lower than 
Losartan-treated group. The lowest dosage (1500mg/kg) was chosen as the effective 
dose. In addition, AESP also manage to improve the morphology structure of thoracic 
aorta and kidney of the rat. The morphology improvement of the organ of interest 
structure can be attributed to the high antioxidant property and phenolic compound 
found in AESP. There was no significant difference in RFT among the experimental 
groups. This suggested that despite there were significant morphological changes on 
the kidney due to 3 months effects of hypertension, their function remains intact. Thus, 
this study strongly suggests that S. polyanthum possess potential as antihypertensive 
agent and can alleviate the effect of end organ damage in hypertension. 
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CHAPTER 1: INTRODUCTION 
 
1.1    Background  
 
Non-Communicable Diseases (NCDs) contribute to an estimated 73% of total 
deaths worldwide, with the biggest contributor being cardiovascular diseases (CVD). 
CVD is responsible for 31% of all death worldwide (World Health Organization, 
2017). The burden of mortality, morbidity and disability due to CVD is currently high 
and continue to grow. The Second Burden of Disease Study for Malaysia, published 
by the Institute for Public Health in 2012, ranked hypertension, smoking, diabetes, 
high cholesterol and high body mass index (BMI) as the biggest contributors to CVD 
and deaths. Data from the previous National Health and Morbidity Surveys (NHMS) 
showed an increasing trend for all NCD risk factors. An analysis of NHMS 2015 
showed that at least 63% of adults aged 18 years and above had at least one NCD risk 
factor either overweight or obesity, high blood pressure, high blood sugar or high 
blood cholesterol. An estimated 35% of deaths occur in individuals aged less than 60 
years, which are mainly due to CVD. The World Health Report in 2013 estimated that 
29% of the world's adult population, or about 1.56 billion people, will have 
hypertension by the year of 2025. In short, Malaysia now has a “sick” or “at risk” 
population. More alarmingly, our children are just as vulnerable to the risk of NCDs 
right from fetal development and increase further during childhood with the exposure 
to unhealthy diets, lack of exercise as well as smoking and excessive alcohol 
consumption (World Health Organization, 2013).  
Hypertension is an increasingly important medical and public health issue 
because of its high prevalence and its detrimental sequelae (Whitworth, 2003; Ezati et 
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al., 2002). Essential hypertension (also called primary hypertension or idiopathic 
hypertension) is the most common type of hypertension, affecting 95% of 
hypertensive patients (Hall et al., 2006; Oparil et al., 2003), it tends to be familial and 
is likely to be the consequence of an interaction between environmental and genetic 
factors. Prevalence of essential hypertension increases with age, and individuals with 
relatively high blood pressure at younger ages are at increased risk for the subsequent 
development of hypertension (Nandhini, 2014). NHMS in 2015 has shown that the 
prevalence of hypertension in Malaysia for adults aging from 18 years old and above 
has increased from 32.2% in 2006 to 32.7% in 2015. Meanwhile, for those individual 
aging above 30 years old, the prevalence has increased from 42.6% to 43.5%. In terms 
of the main ethnic groups, the Bumiputera from Sabah & Sarawak have the highest 
prevalence at 36.4%, followed by the Malays at 34.0%, Chinese at 32.3% and lastly 
the Indians at 30.6% (Institute for Public Health, 2015).  
An analysis of NHMS (Volume III) in 2015 data also has shown that 63% of 
Malaysians had at least one cardiovascular risk factor. Hypertension remains the 
number one risk factor with a prevalence rate of 42.6% in adults above 30 years of 
age, followed by central obesity with 37% prevalence rate, hypercholesterolaemia 
with 24% prevalence rate and hyperglycaemia is the lowest prevalence rate with 15% 
(Goff et al., 2014). The relationship between blood pressure and risk of cardiovascular 
events is continuous, consistent and independent of other risk factors. The higher the 
blood pressure, the greater the chance of myocardial infarction, heart failure, stroke 
and kidney diseases. The presence of each additional risk factor, such as 
dyslipidaemia, diabetes mellitus or smoking status, compounds the risk. Therefore, the 
main aim of identifying and treating hypertension is to reduce these risks of end organ 
damage or end organ complications. This disease is defined as persistent elevation of 
 3 
 
systolic blood pressure of 130-139 mmHg and diastolic blood pressure of 80-89 
mmHg (Table 1.1) (Whelton et al., 2017).  
Evidence from randomized control trials (RCTs) has showed that a small 
reduction in blood pressure may result in a large reduction in the risk of stroke and 
myocardial infarction (Ward et al., 2009; Schmieder, 2005). The antihypertensive 
treatment has made great progress in modern medicine. The therapeutic drugs include 
six classes of antihypertensive agents and fixed compound preparation (Wang & 
Xiong, 2012; Jia et al., 2011; Xu & Chen, 2007). However, there is concern that the 
benefits demonstrated in RCTs of antihypertensive medication are not implemented 
in everyday clinical practice and that the long-term use of western medicine will 
produce some side effects, even produce resistance and affect therapeutic efficacy, 
only 53% of patients treated for hypertension had blood pressure actually controlled 
to ≤140/90 mm Hg (Yoon et al., 2015). Therefore, seeking for a new effective 
decompression method is an important subject of hypertension treatment. 
Complementary and alternative medicine (CAM) is recognized and accepted in 
Europe and America that have developed a high degree of modern medicine, as an 
important complement to the western mainstream medicine system (Wang & Xiong, 
2012; Su & Li, 2011). Recent researches showed that CAM could be regularly 
recommended for lowering elevated blood pressure (Wang & Xiong, 2012; Xiong et 
al., 2012; Xu et al., 2012). 
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Table 1.1:  Definition of hypertension according to blood pressure level in adult 
adapted from ACC/AHA guideline (2017)  
Blood Pressure Category SBP  DBP 
Normal <120 mmHg and <80 mmHg 
Elevated 120-129 mmHg and <80 mmHg 
Hypertension    
Stage 1 130-139 mmHg or 80-89 mmHg 
Stage 2 > 140 mmHg or > 90 mmHg 
 
 
Traditional medicine treatment had been practiced for centuries to cure 
numbers of illness, one of them is hypertension. Amazing number of medicinal 
properties in the nature are being used in preparing the medicine to fight against this 
disease. Active components in the plant are the chemical compound which exists 
naturally and being modified into form of capsules, tablets, liquid, essential oil, 
ointment or teas to correct a lot of physical imbalance that lead to health complications 
(Obidike & Salawu, 2013). Natural products have been widely used as the main 
materials and played a crucial role as the lead compound in the development of new 
drug. Recently, the exploitation on medicinal herbs as alternative medicines in curing 
various type of diseases and infections had increased exponentially. This is due to the 
research claim that these products are safe and free from side effects has been applied 
in the ancient traditional Chinese, Greek- Unani and Ayurveda medicines. 
In this modern era, people are more aware of their health status that leads them 
to find natural-based products to substitute the role of various synthetic products which 
are available in market. According to the World Health Organization (WHO), about 
60-80% of people from developing countries consume traditional medicine for the 
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treatment of various diseases (World Health Organization, 2013). Therefore, herbs and 
medicinal plants are gaining interest because of their potential in healing as natural 
products, which are also known to be good sources to provide better health. 
Continuous research and studies of potential herbs and medicinal plants are important 
as natural products from plant origin will continue to be in demand. In this modern 
era, people are more aware of their health status that leads them to find natural-based 
products to substitute the role of various synthetic products which are available in 
market. 
Malaysia, a tropical Southeast Asia country, is gifted with a rich diversity of 
flora and fauna, particularly, herbs and medicinal plants. Malay people, especially, 
like to consume traditional vegetables, which also known as ulam in their daily diet. 
This is due to the taste (Abas et al., 2006) and aroma which will help in enhancing 
their appetite and promoting a better health for the people. There are more than 120 
species of traditional ulam, varying from shrubs to large trees, which can be found in 
Malaysia. They are usually grown at home and could be found abundantly in local 
market. One of the favorite ulam that have been consumed for ages is Syzygium 
polyanthum (Wight) Walp. There are other previous studies which report that S. 
polyanthum also possesses biological activities such as antioxidant (Raden et al., 
2009), antibacterial (Sumono & Agustin, 2008), antimicrobial, anti-inflammation 
(Wientarsih et al., 2007) and antifungal (Noveriza & Miftakhurohmah, 2010).  
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1.2 Scope of Study 
This study was conducted in orders to investigate the antioxidant activity and 
hypotensive effects of Syzygium polyanthum leaves aqueous extract (AESP) in 
Spontaneous Hypertensive Rat (SHR) for a long-term period (sub-chronic) which is 
92 days. The previous study on hypotensive effect had been done by our group but on 
a short-term basis which were acute (24 hours) and sub-acute study (28 days).  
In this experiment, in-vivo approached has been employed on SHR. AESP was 
prepared using sonication method. The total phenolic content in AESP was evaluated 
using colorimetric method which are Total Phenolic Content (TPC). In current study, 
the antioxidant activity of AESP was determined using Ferric Reducing Antioxidant 
Power (FRAP) assay. Phenolic compounds and antioxidants are known to contribute 
in lowering the blood pressure in previous studies. Apart from measurement of blood 
pressure, the effects of AESP was also evaluated by assessing the changes in 
morphology of kidney and thoracic aorta of the rat.  
As a summary, this study investigated the total phenolic content, antioxidant 
activity and antihypertensive effects of S. polyanthum leaves aqueous extract using 
hypertensive-rat model (SHR). 
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1.3 Research Problem. 
According to the World Health Organization (2013), medicinal plant would be 
the best source to obtain a variety of drug and it was estimated that there were almost 
80% of people in the world still using the traditional herbal drug in daily life to 
maintain their health. Traditional medicine pioneered interventions like healthy diet, 
exercise, herbal remedies, and ways to reduce everyday stress. Traditional medicine 
has much to offer, especially as a contribution to primary health care and universal 
coverage, and most especially at a time when chronic non-communicable diseases was 
depicted as the world’s biggest killer. Despite the growing global demand of herbal 
medicine, there are still concerns associated with not only their use, but their safety. 
Herbal remedies are generally referred to as safe and are presented to the public as 
being “natural” and completely “safe” due to their long history of use (Afolabi et al., 
2012). Although there has been reported increase in the ethnopharmacological 
investigations of medicinal plants in literature, the growing number of herbal product 
users around the globe and lack of scientific data on the safety profile of herbal 
products make it necessary to conduct deeper and more precise study of herbal 
products (Van Wyk et al., 2000).  
Besides that, hypertension remains a major modifiable risk factor for CVD 
despite important advances in our understanding of its pathophysiology and the 
availability of effective treatment strategies. High blood pressure increases the risk of 
CVD for millions of people worldwide, and there is evidence that the problem is only 
getting worse. The incidence of end-stage renal disease and the prevalence of heart 
failure have also increased. A major contributor to these trends is inadequate control 
of BP in the hypertensive population (Greene et al., 2013). 
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1.4 Aim of the Research 
This study was aimed to achieve the following general and specific objectives. 
1.4.1 General objective 
The general objective of this study is to evaluate the S. polyanthum leaves aqueous 
extract as potential antihypertensive agent in spontaneous hypertensive rat model 
(SHR). 
1.4.2 Specific objectives  
• To evaluate the antioxidant properties of S. polyanthum aqueous extract 
(AESP). 
• To evaluate the hypotensive effects of sub-chronic repeated-oral AESP on 
Spontaneous Hypertensive rat’s (SHR) blood pressure using Tail-Cuff method. 
• To evaluate the effects of AESP on SHR’s kidney function using biochemical 
parameters. 
• To evaluate the effects of AESP on morphological changes of SHR’s kidney 
and aorta. 
 
1.5 Research hypothesis 
• AESP has significant antioxidant property. 
• AESP significantly reduce SHR’s blood pressure. 
• AESP improves SHR’s kidney function. 
• AESP improves SHR’s kidney and thoracic aorta morphology. 
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CHAPTER 2: LITERATURE REVIEW 
2.1  Hypertension 
Hypertension or High Blood Pressure, physiological condition involving 
increased pressure on the arterial walls. The American College of 
Cardiology/American Heart Association Task Force on Clinical Practice Guidelines 
in 2017 defined and classified hypertension in adults which is the diagnosis of 
hypertension is made based on an average of more than 2 careful readings of blood 
pressure obtained on more than 2 occasions, the systolic blood pressure measurements 
is higher than 130-139 mmHg and the diastolic blood pressure readings is between 80-
89 mmHg. Blood pressure is the force of blood pushing against blood vessel walls as 
the heart pumps out blood. Abnormal increase in the amount of blood pressure force 
on blood vessels as it moves through the body is called as high blood pressure or 
hypertension (National Institute of Health, 2014).  
Most people without chronic health conditions have a normal blood pressure 
if it stays below than 120 mmHg for systolic and below 80 mmHg for diastolic. 
Elevated blood pressure is a systolic pressure of 120 mmHg to 129 mmHg and a 
diastolic pressure less than 80 mmHg. Stage 1 high blood pressure is a systolic 
pressure of 130mmHg to 139mmHg or a diastolic pressure of 80mmHg to 89mmHg 
or above while, stage 2 high blood pressure is systolic pressure is equal and higher 
than 140mmHg or the diastolic blood pressure is equal and higher than 90mmHg 
(Whelton et al., 2017). Many people have a condition known as labile hypertension, 
in which blood pressure is elevated on initial examination but registers normal on 
subsequent measurements (Trott & Harrison, 2014). For this reasoning, a diagnosis of 
hypertension requires elevated blood pressure readings on several occasions. Elevated 
arterial blood pressure indicates increased arterial resistance to blood flow, but in 90 
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percent of patients no cause for this increased resistance can be identified. These cases 
are called essential hypertension (Natekar et al., 2014). Essential hypertension also 
could be defined as high blood pressure in which secondary causes such as 
renovascular disease, renal failure, pheochromocytoma, aldosteronism, or other causes 
of secondary hypertension are not present (Marques et al., 2015). This type of 
hypertension accounts for 95% of all cases of hypertension. It is a heterogeneous 
disorder, with different patients having different causal factors that lead to high blood 
pressure. Essential hypertension needs to be separated into various syndromes because 
the causes of high blood pressure in most patients presently classified as having 
essential hypertension can be recognized. Indeed, in Stage 1 hypertension, treatment 
of hypertension (systolic 130–139 mmHg, diastolic 80-89 mmHg), reduces the 
prevalence of left ventricular hypertrophy, a predictor of future morbidity and 
mortality (Whelton et al., 2017; Egan et al., 2014; Ehret & Caulfield, 2013; Coffman, 
2011). There is also a 42% reduction of the risk of stroke and a reduction in the risk 
of dementia. Essential hypertension remains a major modifiable risk factor for CVD 
despite important advances in our understanding of its pathophysiology and the 
availability of effective treatment strategy.  
Secondary hypertension can be the outcome of pregnancy, vascular or kidney 
diseases, or endocrine tumours. Hypertension related to a specific aetiology like this 
is markedly differing from essential hypertension, of which the aetiology cannot be 
identified, in the condition and therapeutic strategies. Secondary hypertension is often 
resistant hypertension, for which a target blood pressure is difficult to achieve by 
standard treatment. It has been recognized that secondary hypertension accounts for 
almost 10% of hypertensive patients (Forman et al., 2008). As secondary hypertension 
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is often resistant to treatment, the incidence of secondary hypertension in patients with 
a resistance-resistant hypertension may be higher. 
 
Figure 2.1: The changes in the diameter of blood vessel with different amount of 
blood pumped through it (National Institute of Diabetes, Digestive and Kidney 
Disease, 2014). 
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2.1.1 Aetiology of Hypertension 
Aetiological factors correlated with hypertension in adults have also been 
associated with blood pressure elevations in youth. In addition to that, lack of physical 
activity or sedentary lifestyle may increase the risk of developing hypertension by 20-
50% (Carretero & Oparil, 2000). Besides that, intrauterine malnutrition, family history 
of hypertension, obesity in particularly excess abdominal fat, insulin resistance, high 
dietary sodium intakes, low dietary intakes of calcium, potassium and magnesium, 
physical inactivity, high alcohol intakes, tobacco use, drug use (cocaine, ecstasy, 
anabolic steroids), emotional stress, diet pill use, oral contraceptives are many other 
factors associated with development of hypertension (Nandhini, 2014; Carretero & 
Oparil, 2000).  
An inadequate supply of nutrients may program changes in foetal structure and 
metabolism, increasing the risk of hypertension and other diseases in later life. 
Hyperinsulineamia and insulin resistance are also associated with the development of 
hypertension which leads to many problems (Nandhini, 2014; Contreras et al., 2000). 
Frequent etiological factors for secondary hypertension include renal parenchymal 
hypertension, primary aldosteronism (PA), renovascular hypertension and sleep apnea 
syndrome. Renal parenchymal hypertension is caused by glomerular diseases, such as 
chronic glomerulonephritis and diabetic nephropathy, interstitial kidney diseases, such 
as chronic pyelonephritis, and polycystic kidney disease (PKD) (Oparil et al., 2003). 
As other etiological factors for secondary hypertension, the following conditions have 
been reported: in endocrine hypertension, phaeochromocytoma and Cushing’s 
syndrome are related to an excessive production of catecholamines and cortisol, 
respectively. Hypothyroidism, hyperthyroidism, hyperparathyroidism and acromegaly 
are also etiologically involved in hypertension (Bartosh & Aronson, 1999). 
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2.1.2 Pathophysiology of hypertension. 
Hypertension is a chronic elevation of blood pressure that, in the long-term 
will causes end-organ damage and results in increased morbidity and mortality. Blood 
pressure is the product of cardiac output and systemic vascular resistance. Patients 
with arterial hypertension may have an increase in cardiac output or systemic vascular 
resistance, or both (Cain & Khalil, 2002). In the younger age group, the cardiac output 
is often elevated, while in older patients increased systemic vascular resistance and 
increased stiffness of the vasculature play a dominant role. Vascular tone may be 
elevated because of increased α-adrenoceptor stimulation or increased release of 
peptides such as angiotensin or endothelins (Prys-Roberts, 2002).  
The final pathway is an increase in cytosolic calcium in vascular smooth 
muscle causing vasoconstriction. Several growth factors, including angiotensin and 
endothelins, cause an increase in vascular smooth muscle mass termed vascular 
remodelling. Both an increase in systemic vascular resistance and an increase in 
vascular stiffness augment the load imposed on the left ventricle, this induces left 
ventricular hypertrophy and left ventricular diastolic dysfunction (Yusuf et al., 2000). 
In youth, the pulse pressure generated by the left ventricle is relatively low and the 
waves reflected by the peripheral vasculature occur mainly after the end of systole, 
thus increasing pressure during the early part of diastole and improving coronary 
perfusion (Osmond & Barker, 2000). With ageing, stiffening of the aorta and elastic 
arteries increases the pulse pressure. Reflected waves move from early diastole to late 
systole. This results in an increase in left ventricular afterload, and contributes to left 
ventricular hypertrophy (Williams et al., 2014; Howell et al., 1997). The widening of 
the pulse pressure with ageing is a strong predictor of coronary heart disease.  
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The autonomic nervous system plays an important role in the control of blood 
pressure. In hypertensive patients, both increased release of, and enhanced peripheral 
sensitivity to, norepinephrine can be found. In addition, there is increased 
responsiveness to stressful stimuli (Loscalzo, 2008). Another feature of arterial 
hypertension is a resetting of the baroreflexes and decreased baroreceptor sensitivity. 
The renin–angiotensin system is involved at least in some forms of hypertension and 
is suppressed in the presence of primary hyperaldosteronism (Jürgens & Graudal, 
2004). The protease renin cleaves angiotensin to yield converted into an active 
octapeptide, angiotensin II by the angiotensin-converting enzyme (ACE) (Osmond & 
Barker, 2000). Though the renin–angiotensin system is widespread in the body, the 
main source of renin is the juxtaglomerular apparatus of the kidney. This apparatus 
senses the renal perfusion pressure and the sodium concentration in the distal tubular 
fluid (MacGregor et al., 2006) High angiotensin II concentrations suppress renin 
secretion via a negative feedback loop. Angiotensin II acts on specific angiotensin 
AT1 and AT2 receptors causing smooth muscle contraction and the release of 
aldosterone, prostacyclin, and catecholamines (Anand, 1999; Nakao et al., 1999). The 
renin–angiotensin–aldosterone system (RAAS) plays an important role in the control 
of arterial pressure including the sodium balance. Elderly or black patients tend to 
have low-renin hypertension. Others have high-renin hypertension and these are more 
likely to develop myocardial infarction and other cardiovascular complications (Sever 
& Poulter, 1989; Beilin, 1988).  
  In human essential hypertension, volume regulation and the relationship 
between blood pressure and sodium excretion (pressure natriuresis) are abnormal 
(INTERSALT, 1988). The primary cause of sodium and water retention may be an 
abnormal relationship between pressure and sodium excretion resulting from reduced 
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renal blood flow, reduced nephron mass, and increased angiotensin or 
mineralocorticoids (Gates et al., 1996). Considerable evidence indicates that resetting 
of pressure natriuresis plays a key role in causing hypertension. Sodium and water 
retention are associated with an increase in blood pressure. It is postulated that sodium, 
via the sodium–calcium exchange mechanism, causes an increase in intracellular 
calcium in vascular smooth muscle resulting in increased vascular tone (Findling, 
1997; Hansson, 1995). In patients with essential hypertension, resetting of pressure 
natriuresis is characterized either by a parallel shift to higher blood pressures and salt-
insensitive hypertension, or by a decreased slope of pressure natriuresis and salt 
sensitive hypertension (Mune et al., 1995). 
 
 
Figure 2.2: System that involved in the developement and maintainance of 
hypertension (Delacroix et al., 2014). 
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2.2 Hypertension and kidney 
The kidneys are two bean-shaped organs, each about the size of a fist. They 
are located just below the rib cage, one on each side of the spine (NIDDK, 2012). 
Every day, the two kidneys filter about 120 to 150 quarts of blood to produce about 1 
to 2 quarts of urine, composed of wastes and extra fluid (Campese et al., 2006). The 
urine flows from the kidneys to the bladder through tubes called ureters. The bladder 
stores urine. When the bladder empties, urine flows out of the body through a tube 
called the urethra, located at the bottom of the bladder (Levey et al., 2003). In men the 
urethra is long, while in women it is short. Kidneys work at the microscopic level. The 
kidney is not one large filter (Casas et al., 2005). Each kidney is made up of about a 
million filtering units called nephrons. Each nephron filters a small amount of blood. 
The nephron includes a filter, called the glomerulus, and a tubule. The nephrons work 
through a two-step process (Gudbjartsson, 2010). The glomerulus lets fluid and waste 
products pass through it; however, it prevents blood cells and large molecules, mostly 
proteins, from passing. The filtered fluid then passes through the tubule, which sends 
needed minerals back to the bloodstream and removes wastes (Kottgen et al., 2009). 
The final product becomes urine. 
 
Figure 2.3: Kidney and nephron anatomy in human body (USA National Institute of 
Health, 2015).  
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The incidence of end-stage renal failure has increased despite advances in 
antihypertensive treatment, but has recently decreased slightly (Araujo & Wilcox, 
2014). Patients in whom haemodialysis was initiated in 2011, the most frequent 
underlying disease was diabetic nephropathy with percentage of 44.3%, with chronic 
glomerulonephritis being the second most frequent with 20.2% and nephrosclerosis 
being the third with 11.8%. Most of these chronic kidney diseases (CKDs) induce 
hypertension, but hypertension promotes the progression of kidney damage and 
establishes a vicious circle leading to end stage renal failure (NIDDK, 2012). 
As there is no radical treatment for CKD at present, blood pressure control by 
antihypertensive drug therapy primarily using RA system inhibitors (angiotensin II 
receptor blockers (ARBs) or angiotensin-converting enzyme (ACE) inhibitors) is 
extremely important for the prevention of end-stage renal failure (Zhu et al., 2009). 
As there is a close relationship between CKD and hypertension, it is often difficult to 
determine which came first, CKD or hypertension, if they are concurrent. If abnormal 
findings have been obtained on urinalysis, or renal dysfunction has appeared before 
hypertension, or if the presence of hypertension, proteinuria or renal dysfunction from 
an early phase of pregnancy can be confirmed, hypertension is likely to be caused by 
CKD (Pallone et al., 2012). Also, if hypertension is mild relative to abnormal urinary 
findings or kidney damage, or if there are few hypertensive cardiovascular 
complications concurrent with the kidney disorders, CKD is considered to underlie the 
hypertension (Hanssons et al., 2000). Urinalysis and measurement of the serum 
creatinine concentration should be performed in all hypertensive patients, and, if an 
abnormality persists, kidney morphology must be evaluated using abdominal 
ultrasonography or CT. 
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2.3  Antioxidants, Oxidative Stress and Reactive Oxygen Species (ROS). 
Since the late 19th and early 20th century, chemists have studied antioxidants, 
a loosely defined group of compounds characterized by their ability to be oxidized in 
place of others compounds present. Biologists realized the importance of antioxidants 
in health with the 1960s publications of vitamins and flavanoids, followed by later 
research in the 1970s on ascorbic acid (vitamin C), cancer, and the common cold 
(Cameron & Pauling, 1976). Scientists actively researching and discussing on 
antioxidants as protecting agent (Ganesan et al., 2015; Shilpa et al., 2014; Srimuwarni, 
2005) explanations for the effects of antioxidants on cancer susceptibility and overall 
health expanded rapidly in subsequent decades with research into mechanisms, 
molecular targets, and molecular interactions (American Institute of Cancer Research, 
2007).  
Antioxidants are agents that at low concentrations prevent or inhibit oxidation 
of oxidisable biomolecules, such as DNA, lipids, and proteins. In biological systems, 
enzymatic and non-enzymatic systems have evolved to protect against oxidative 
damage. Major enzymatic antioxidants are SOD, catalase, glutathione peroxidases, 
thioredoxin, and peroxiredoxin (Gongora et al., 2006). Non-enzymatic antioxidants 
include ascorbate, tocopherols, glutathione, bilirubin, and uric acid (Chen et al., 2001). 
Low antioxidant bioavailability promotes cellular oxidative stress and has been 
implicated in cardiovascular and renal oxidative damage associated with hypertension.  
During normal cellular metabolism, several enzymes are capable of transferring 
electrons from an electron donor to molecular oxygen (Araoujo & Wilcox, 2014). 
These include the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, 
xanthine oxidase, mitochondrial electron transport, and, under certain circumstances, 
nitric oxide (NO) synthase (Lushchack, 2014; Harrison & Dikalov, 2005). The 1-
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electron oxidation product of oxygen yields superoxide (O2 
-), while a 2-electron 
reduction of oxygen results in formation of hydrogen peroxide (H2O2). These are 
referred to as ROS, and they can undergo numerous subsequent reactions leading to 
production of many other ROS (San Martin & Griendling, 2014). 
  The formation of ROS is a natural consequence of aerobic metabolism and is 
integral for maintaining tissue oxygen homeostasis (Castro & Freeman, 2001). 
Oxygen homeostasis which is the balance between constitutive oxidants and 
antioxidants, is maintained through a natural series of reduction–oxidation (redox) 
reactions involving the transfer of electrons between two chemical species: 
compounds that lose electrons (oxidised) and those that gain electrons (reduced) (Ray 
et al., 2012). When oxygen homeostasis is not maintained, the cellular environment 
becomes oxidatively stressed. Approximately, 1–3% of oxygen consumed by the body 
is converted into ROS (Finkel & Holbrook, 2000).Three of the major ROS which are 
superoxide radical, hydrogen peroxide and hydroxyl radical are normal metabolic 
byproducts that are generated continuously by the mitochondria in growing cells 
(Seifried et al., 2006; Lopaczynski & Zeisel, 2004; McCord, 2000) Potentially 
damaging oxidative stress can be generated by excess ROS, which are kept in check 
by endogenous cellular antioxidant mechanisms. Increase of ROS levels influence 
activity of signal transduction pathways leading to cell proliferation, or to apoptosis 
or necrosis, depending on the dosage and duration of ROS and also on cell type. 
Typically, low doses of ROS can be mitogenic, whereas medium doses lead to 
temporary or permanent growth arrest which also could be called as replicative 
senescence and high doses usually result in cell death either by apoptosis or necrosis 
(Holbrook & Ikeyama, 2002). The chemistry of these reactions as they pertain to 
vascular biology and hypertension has recently been reviewed in depth.  
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Oxidative stress is a state of imbalance between oxidants or also called ROS 
and antioxidants in favour of the oxidants, leading to damaging effects (Makino et al., 
2002; Zalba et al., 2001; Lacy et al., 2000). Physiologically, our bodies' own 
antioxidant defence systems are capable of adapting to the changing levels of oxidants 
in order to maintain the oxidant-antioxidant balance (Sies, 2007) This antioxidant 
defence system includes enzymes such as superoxide dismutase, glutathione 
peroxidase and catalase, non-enzyme molecules including albumin, bilirubin and 
glutathione (Wang et al. 2013), the molecular regulatory mechanism by Nrf2/ARE-
mediated antioxidant gene expression (Mann et al. 2007) as well as micronutrients and 
vitamin (Sies, 2007). However, in pathophysiological conditions, the production of 
ROS exceeds the natural antioxidant defence of the cells, causing the active ROS to 
attack and producing cellular alterations (Majzunova et al. 2013; Vaziri, 2008). 
Oxidative stress and inflammation are closely interrelated, since oxidative stress can 
cause inflammation, which in turn can induce oxidative stress (Ishibashi et al., 2013). 
Both oxidative stress and inflammation cause injury to cells (Onuf, 2012) and giving 
rise to endothelial dysfunction (McCord, 2000). 
 
Figure 2.4: Main causes of essential hypertension and its complications, from 
O'Shaughnessy (2001). 
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2.4 Vascular Remodelling 
Pathophysiological mechanisms that contribute to high blood pressure are 
complex and involve many biological systems. One of the most importance biological 
system is the vascular system, which exhibits characteristic changes notably 
endothelial dysfunction, vascular remodelling, and vascular inflammation (Montezano 
et al., 2014; Savoia et al., 2011). These changes are the cause and consequence of high 
blood pressure and are therefore attractive targets for antihypertensive therapy. 
Endothelial dysfunction is characterized by a state of reduced vasodilation, increased 
vasoconstriction, adhesion of pro-inflammatory monocytes with coagulation, and loss 
of integrity of the endothelial monolayer (Figure 2.9) (Xiao et al., 2014; Drummond 
et al., 2011). Associated with these functional changes are structural alterations of 
arterial remodelling, characterized by an increased media to lumen ratio (Schiffrin, 
2012). Common to these processes are alterations in endothelial cells and vascular 
smooth muscle cells (VSMCs) to a vasoconstrictor, mitogenic, profibrotic, 
promigratory and pro-inflammatory, phenotype influenced by oxidative stress or 
increased bioavailability of ROS (Vukelic & Griendling, 2014; Xu et al., 2009). 
Results from a meta-analysis showed that the DASH diet, rich in antioxidants 
from fruits and vegetables, is associated with significant blood pressure lowering and 
a reduction of 13% in the 10-year Framingham risk score for cardiovascular disease 
(Hoagland et al., 2003). Increasing antioxidant capacities through foods and drinks 
that contain flavonoids has also been shown to improve endothelial function in some 
patients with hypertension (Xiao et al., 2014; Xu et al., 2009). Studies in hypertensive 
patients demonstrated that consumption of dark chocolate, black tea, and red wine 
increased flow mediated dilation and improved endothelial function (Diplock, 2000; 
Löliger, 1991) Epidemiological studies have linked low dietary intake of antioxidant 
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vitamins (vitamin C, vitamin E, ß-carotene, polyphenol) with cardiovascular disease. 
Antioxidant vitamins influence endothelial function and vascular contractility. Intra-
arterial administration of high doses of vitamin C improved endothelium-dependent 
vasodilation in the forearm microcirculation of hypertensive patients, by increasing 
NO bioavailability (Aruoma, 1991; Gutteridge & Halliwell, 1989; Southorn & Powis, 
1988). Proteins that contain cysteine residues are highly sensitive to oxidative 
modification. These oxidative modifications lead to changes in structure, activity, and 
function of target proteins (Andersen, 2004). Proteins that are redox-sensitive include 
ion transporters, receptors, kinases, phosphatases, transcription factors, structural 
proteins, and matrix metalloproteases, all of which are important in regulating 
endothelial and VSMC function (Becker, 2007; Baud & Karin, 2001). ROS also 
regulate prostaglandin production and signalling, important in regulating vascular 
function. In hypertension, oxidative stress induces increased production of prostanoids 
by constitutive (COX-1) and inducible (COX-2) cyclooxygenases, which lead to 
increased vasoconstriction and reduced endothelium-dependent vasodilation (Berry & 
Hare, 2004). H2O2 stimulates production of vasoconstrictor prostanoids thromboxane, 
prostacyclin and prostaglandin E2, which cause vasoconstriction in hypertension. 
Figure 2.5: Mechanism of ROS which cause the occurrence of endothelial 
dysfunction and eventually lead to hypertension (Montezano, 2014). 
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2.5 Spontaneous Hypertensive Rats (SHR) 
 
A great expansion of experimental research began with the development of rat 
strains with genetically inherited hypertension. The SHR offers specific and uniform 
genetic predisposition, thus allowing the study of the causes, mechanisms, and 
pathology of hypertension, as well as its behavioural consequences, and the 
comparison of the efficacy of proposed therapeutic interventions in relation to existing 
clinical treatments (Kannel, 1993). Moreover, central neurohormonal mechanisms 
which constitute the dominating trigger influence in SHR and provide a model of 
hypertension that allows the study of the combined influence of both aging and 
hypertension on cognitive and physical functions on different developmental stages 
(Hanes et al., 1996; Weindruch, 1995). Notwithstanding, the SHR is a genetic model, 
and the appearance of neural disturbances could be a parallel genetic phenomenon and 
not necessarily or exclusively related to the elevated blood pressure (Bohr et al., 1991). 
Normal aging also produces a slow decline in neuron population, tissue distensibility, 
basal metabolic rate, and oxygen consumption, thus affecting cardiovascular 
performance (Meneses & Hong, 1998). There is an extensive range of rat models, most 
mimic some aspects of the relevant human disease. No model mimics exactly all the 
symptoms of the human disease, partly because many of changes in the human disease 
are not thoroughly understood (Doggrell & Brown, 1998).    
SHRs are descendants of an outbred Wistar male with spontaneous 
hypertension from a colony in Kyoto, Japan; mating with a female with an elevated 
blood pressure, and then brother X sister mating continued with selection for 
spontaneous hypertension, defined as a systolic blood pressure of over 150 mmHg 
persisting for more than one month (Okamoto & Aoki, 1963). From 1968, this inbred 
strain of SHRs was further developed in the USA (Kurtz & Morris, 1987). The various 
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colonies of SHR are pre-hypertensive for the first 6–8 weeks of their lives with systolic 
blood pressures around 100–120 mmHg (Adams et al., 1989) and then hypertension 
develops over the next 12–14 weeks (McGuire & Tweitmeyer, 1985). As in humans, 
hypertension develops more rapidly and becomes more severe in male than female 
SHR (Iams & Wexler, 1979). In vivo studies have shown that, in the early stages of 
hypertension, SHRs have an increased cardiac output with normal total peripheral 
resistance. As the SHR progresses into the established hypertension state, the cardiac 
output returns to normal and the hypertrophied blood vessels produce an increase in 
the total peripheral resistance (Smith & Hutchins, 1979).  
The male SHR is commonly used as a model of established human 
hypertension (Takata & Kato, 1996), and to test new antihypertensive medication, for 
example felodipine (Lund, 1990). Human hypertension is difficult to study as there is 
substantial individual variation in the two triggering elements of hypertension, 
polygenetic disposition and excitatory environmental factors, leading to many 
variations in the direct and indirect effects on the cardiovascular system that are 
difficult to differentiate. Researchers in hypertension have commonly resorted to the 
use of SHRs which have, within each colony, uniform polygenetic disposition and 
excitatory factors which produce uniform changes in the indirect and direct effects on 
the cardiovascular system. This lack of inter-individual variation is one of the major 
advantages of the SHR (Lindpaintner et al., 1992).  
Another advantage of the SHR is that it follows the same progression of 
hypertension as human hypertension with pre-hypertensive, developing and sustained 
hypertensive phases with each phase lasting at least several weeks. In addition, the 
normal life spans of normotensive and SHRs are comfortably short, which is 2.5–3 
years and 1.5–2.5 years, respectively, to make it relatively easy to follow ‘cradle to 
